» Articles » PMID: 27477697

Cyclin G2 Inhibits Epithelial-to-mesenchymal Transition by Disrupting Wnt/β-catenin Signalling

Overview
Journal Oncogene
Date 2016 Aug 2
PMID 27477697
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

N-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma.

Chen B, Jiang W, Huang Y, Zhang J, Yu P, Wu L Oncogene. 2022; 41(15):2239-2253.

PMID: 35217794 DOI: 10.1038/s41388-022-02250-9.


MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies.

Seo H, Moeng S, Sim S, Kuh H, Choi S, Park J Cells. 2019; 9(1).

PMID: 31861937 PMC: 7016872. DOI: 10.3390/cells9010029.


miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.

Salem M, Shan Y, Bernaudo S, Peng C Int J Mol Sci. 2019; 20(8).

PMID: 31013711 PMC: 6515004. DOI: 10.3390/ijms20081810.


Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling.

Zhao C, Gao J, Li S, Liu Q, Hou X, Liu S Biomed Res Int. 2018; 2018:6938482.

PMID: 30420966 PMC: 6215590. DOI: 10.1155/2018/6938482.


Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells.

Bernaudo S, Khazai S, Honarparvar E, Kopteva A, Peng C PLoS One. 2017; 12(6):e0179906.

PMID: 28640887 PMC: 5481008. DOI: 10.1371/journal.pone.0179906.